Table I.
Correlation of CMIP expression with clinicopathological parameters from gastric cancer patients.
| CMIP expression | |||
|---|---|---|---|
| Parameter | n | Positive, n (%) | P-value |
| Age (years) | |||
| ≤60 | 53 | 39 (73.6) | 0.708 |
| >60 | 47 | 33 (70.2) | |
| Sex | |||
| Male | 54 | 35 (64.8) | 0.083 |
| Female | 46 | 37 (80.4) | |
| Tumor size (cm) | |||
| ≤5 | 67 | 43 (64.2) | 0.013 |
| >5 | 33 | 29 (87.9) | |
| Lymph node metastasis | |||
| No | 37 | 20 (54.1) | 0.002 |
| Yes | 63 | 52 (82.5) | |
| Grade | |||
| I | 7 | 3 (42.9) | 0.010 |
| II | 62 | 41 (66.1) | |
| III | 31 | 28 (90.3) | |
| Stage | |||
| I–II | 54 | 34 (63.0) | 0.029 |
| III–IV | 46 | 38 (82.6) | |
CMIP, c-Maf inducing protein.